HPR155 Patient-Reported Outcomes Used for Regulatory Approval of Oncology Medicinal Products in the European Union Between 2021 and 2024: A Review Update
Dec 1, 2025, 00:00
10.1016/j.jval.2025.09.1562
https://www.valueinhealthjournal.com/article/S1098-3015(25)04119-1/fulltext
Title :
HPR155 Patient-Reported Outcomes Used for Regulatory Approval of Oncology Medicinal Products in the European Union Between 2021 and 2024: A Review Update
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(25)04119-1&doi=10.1016/j.jval.2025.09.1562
First page :
Section Title :
Open access? :
No
Section Order :
11101